ADVISORY BUSINESS HealthCor Partners Management, L.P. was established in 2007 and is controlled by its general partner, HealthCor Partners Management GP, LLC. The principals include Jeffrey Lightcap, Joseph Healey and Arthur Cohen. HealthCor Partners formed HealthCor Partners Fund, L.P. (“Fund I”) in 2008 and HealthCor Partners Fund II, L.P. (“Fund II”) in 2011 (each a “Fund” and collectively, the “Funds”), to make privately negotiated investments primarily in growth equity and later stage developmental companies in the healthcare and life sciences industry. The principals also manage a special purpose vehicle (“SPV”) that was formed to facilitate a co-investment opportunity in a portfolio investment of the Funds by interested limited partners and members of the general partner. HealthCor Partners manages the operations of the Funds and has the right to execute and deliver documents on behalf of each of the Funds in lieu of each Fund’s general partner. Additionally, HealthCor Partners has discretionary authority with respect to investments of the Funds, including but not limited to the authority to investigate, analyze, structure and negotiate potential investments and to evaluate, monitor, exercise voting rights, advise as to disposition opportunities and take other appropriate action with respect to investments on behalf of the Funds. The Funds are offered only to accredited investors, qualified clients, qualified purchasers (or certain non-U.S. persons) and certain employees of HealthCor Partners and its affiliates. HealthCor Partners focuses primarily on early or near-commercial stage businesses in the medical technology, healthcare services, healthcare information technology, therapeutics, and diagnostics sectors that are at or approaching an inflection point in their

growth. HealthCor Partners seeks to generate returns derived primarily from portfolio company growth rather than financial leverage. HealthCor Partners currently does not provide investment advisory services to clients apart from the management of the Funds and any co-investment vehicles structured to facilitate investments by certain limited partners of the Funds, affiliates of the Adviser and third-party investors, and does not directly provide investment advisory services for individual investors. HealthCor Partners does not participate in wrap fee programs. In accordance with common industry practice, HealthCor Partners may from time to time enter into letter agreements or other similar agreements (referred to as “side letters”) with one or more investors in the Funds which provide such investors with additional and/or different rights than such investors have pursuant to general terms of such collective investment vehicle. The Adviser is not required to notify any or all of the other investors of any such written agreements or any of the rights and/or terms or provisions thereof, nor is the Adviser required to offer such additional and/or different rights and/or terms to any or all of the other investors. Once invested in a Fund, investors cannot impose additional investment guidelines or restrictions on such Fund. HealthCor Partners’ activities for each of the Funds are further described in each Fund’s respective offering memorandum, governing agreement, and management agreement. These Fund documents also detail the various investment restrictions that govern the types of investments each Fund may and may not make. As of December 31, 2023, HealthCor Partners’ regulatory assets under management were approximately $ 170,849,175.